The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: A systematic review and meta-analysis of randomised-controlled trials

British Journal of Nutrition

Volumn 116, Issue 8, 2016, Pages 1369-1382

  Ho, Hoang V T ^a,c   Sievenpiper, John L ^a,b,c   Zurbau, Andreea ^a,c   Blanco Mejia, Sonia ^a,c   Jovanovski, Elena ^a,c   Au Yeung, Fei ^a,c   Jenkins, Alexandra L ^a   Vuksan, Vladimir ^a,b,c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cholesterol lowering properties; CVD; Oats; Systematic reviews and meta analyses; Glucan

Indexed keywords

APOLIPOPROTEIN B; BETA GLUCAN; CHOLESTEROL ESTER; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NON HIGH DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT;

CARDIOVASCULAR DISEASE; CINAHL; COCHRANE LIBRARY; EMBASE; FOLLOW UP; HUMAN; INFORMATION RETRIEVAL; MEDLINE; META ANALYSIS; OAT; REVIEW; RISK REDUCTION; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; ADMINISTRATION AND DOSAGE; AGONISTS; ANTAGONISTS AND INHIBITORS; AVENA; BLOOD; CARDIOVASCULAR DISEASES; CHEMISTRY; DIET THERAPY; DIETARY FIBER; DIETARY SUPPLEMENT; EVIDENCE BASED MEDICINE; FUNCTIONAL FOOD; HYPERCHOLESTEROLEMIA; MIDDLE AGED; PATHOPHYSIOLOGY; PLANT SEED; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; SOLUBILITY; THERAPEUTIC USE;

ANTICHOLESTEREMIC AGENTS; APOLIPOPROTEINS B; AVENA; BETA-GLUCANS; BIOMARKERS; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY FIBER; DIETARY SUPPLEMENTS; EVIDENCE-BASED MEDICINE; FUNCTIONAL FOOD; HUMANS; HYPERCHOLESTEROLEMIA; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; SEEDS; SOLUBILITY;

EID: 84992397211     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711451600341X     Document Type: Review

References (81)

1. de Groot A, Luyken R & Pikaar NA (1963) Cholesterollowering effect of rolled oats. Lancet (London, England) 2, 303-304.
2. Food Directorate Health Products and Food Branch, Health Canada (2010) Oat Products and Blood Cholesterol Lowering. Ottawa: Bureau of Nutritional Sciences.
3. Food and Drug Administration (1997) Food Labeling: Health Claims; Oats and Coronary Heart Disease. Maryland: Health and Human Services.
4. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2011) Scientific opinion on the substantiation of health claims related to beta-glucans from oats and barley and maintenance of normal blood LDL-cholesterol concentrations (ID 1236, 1299), increase in satiety leading to a reduction in energy intake (ID 851, 852), reduction of post-prandial glycaemic responses (ID 821, 824), and 'digestive function' (ID 850) pursuant to Article 13(1) of Regulation (EC) No 1924/ 2006. EFSA J 9, 2207.
5. The Board of Food Standards Australia New Zealand (2013) Food Standards, Vol. 1. 2. 7: Nutrition, Health and Related Claims. Canberra: Commonwealth of Australia.
6. Ministry of Health Malaysia (2014) Malaysian dietary guidelines - Key Message 14 - make effective use of nutrition information on food labels. Putrajaya, Malaysia: Ministry of Health Malaysia. www. moh. gov. my/images/gallery/ Garispanduan/diet/km14. pdf (accessed November 2014).
7. Saenger A (2011) Cardiovascular Risk Assessment Beyond LDL Cholesterol: Non-HDL Cholesterol, LDL Particle Number, and Apolipoprotein B. Mayo Clinic Communique. http:// www. mayomedicallaboratories. com/articles/communique/2011/ 11 html (accessed April 2015).
8. National Cholesterol Education Program (NCEP) Expert Panel (2002) Third report on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106, 3143-3421.
9. Anderson TJ, Gregoire J, Hegele RA, et al. (2013) 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol 29, 151-167.
10. The Cochrane Collaboration (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5. 1. 0 [J Higgins and S Green, editors]. www. cochrane-handbook. org
11. Moher D, Liberati A, Tetzlaff J, et al. (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6, e1000097.
12. Panahi S (2006) The effect of oat beta-glucan on glycemia and blood lipid risk factors for cardiovascular disease. Thesis, University of Toronto.
13. Food and Drug Administration (2009) Labeling & Nutrition: Guidance for Industry: Evidence-Based Review System for the Scientific Evaluation of Health Claims-Final. http://www. fda. gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatory Information/LabelingNutrition/ucm073332. htm.
14. Greer N, Mosser G, Logan G, et al. (2000) A practical approach to evidence grading. Jt Comm J Qual Improv 26, 700-712.
15. Kris-Etherton PM & Dietschy J (1997) Design criteria for studies examining individual fatty acid effects on cardiovascular disease risk factors: human and animal studies. Am J Clin Nutr 65, Suppl., 1590S-1596S.
16. Chen WJ & Anderson JW (1981) Soluble and insoluble plant fiber in selected cereals and vegetables. Am J Clin Nutr 34, 1077-1082.
17. Anderson JW & Bridges SR (1988) Dietary fiber content of selected foods. Am J Clin Nutr 47, 440-447.
18. Whitehead A, Beck EJ, Tosh S, et al. (2014) Cholesterollowering effects of oat beta-glucan: a meta-analysis of randomized controlled trials. Am J Clin Nutr 100, 1413-1421.
19. Heyland DK, Novak F, Drover JW, et al. (2001) Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 286, 944-953.
20. Ha V (2013) Effects of dietary pulses on lipid risk factors of cardiovascular disease and oxidative stress. University of Toronto.
21. Elbourne DR, Altman DG, Higgins JP, et al. (2002) Metaanalyses involving cross-over trials: methodological issues. Int J Epidemiol 31, 140-149.
22. Amundsen ÅL, Haugum B & Andersson H (2003) Changes in serum cholesterol and sterol metabolites after intake of products enriched with an oat bran concentrate within a controlled diet. Scand J Nutr 47, 68-74.
23. Anderson JW, Gilinsky NH, Deakins DA, et al. (1991) Lipid responses of hypercholesterolemic men to oat-bran and wheat-bran intake. Am J Clin Nutr 54, 678-683.
24. Berg A, Konig D, Deibert P, et al. (2003) Effect of an oat bran enriched diet on the atherogenic lipid profile in patients with an increased coronary heart disease risk. A controlled randomized lifestyle intervention study. Ann Nutr Metab 47, 306-311.
25. Biorklund M, van Rees A, Mensink RP, et al. (2011) Changes in serum lipids and postprandial glucose and insulin concentrations after consumption of beverages with beta-glucans from oats or barley: a randomised dose-controlled trial. Eur J Clin Nutr 59, 1272-1281.
26. Biorklund M, Holm J & Onning G (2008) Serum lipids and postprandial glucose and insulin levels in hyperlipidemic subjects after consumption of an oat beta-glucan-containing ready meal. Ann Nutr Metab 52, 83-90.
27. Braaten JT, Wood PJ, Scott FW, et al. (1994) Oat beta-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects. Eur J Clin Nutr 48, 465-474.
28. Bremer JM, Scott RS & Lintott CJ (1991) Oat bran and cholesterol reduction: evidence against specific effect. Aust N Z J Med 21, 422-426.
29. Charlton KE, Tapsell LC, Batterham MJ, et al. (2012) Effect of 6 weeks' consumption of beta-glucan-rich oat products on cholesterol levels in mildly hypercholesterolaemic overweight adults. Br J Nutr 107, 1037-1047.
30. Davidson MH, Dugan LD, Burns JH, et al. (1991) The hypocholesterolemic effects of beta-glucan in oatmeal and oat bran. A dose-controlled study. JAMA 265, 1833-1839.
31. Demark-Wahnefried W, Bowering J & Cohen PS (1990) Reduced serum cholesterol with dietary change using fatmodified and oat bran supplemented diets. J Am Diet Assoc 90, 223-229.
32. Johnston L, Reynolds HR, Hunninghake DB, et al. (1998) Cholesterol lower benefits of a whole grain oat readyto-eat cereal. Nutr Clin Care 1, 6-12.
33. Karmally W, Montez MG, Palmas W, et al. (2005) Cholesterollowering benefits of oat-containing cereal in Hispanic Americans. J Am Diet Assoc 105, 967-970.
34. Kerckhoffs DA, Hornstra G & Mensink RP (2003) Cholesterollowering effect of beta-glucan from oat bran in mildly hypercholesterolemic subjects may decrease when betaglucan is incorporated into bread and cookies. Am J Clin Nutr 78, 221-227.
35. Kestin M, Moss R, Clifton PM, et al. (1990) Comparative effects of three cereal brans on plasma lipids, blood pressure, and glucose metabolism in mildly hypercholesterolemic men. Am J Clin Nutr 52, 661-666.
36. Leadbetter J, Ball MJ & Mann JI (1991) Effects of increasing quantities of oat bran in hypercholesterolemic people. Am J Clin Nutr 54, 841-845.
37. Lepre F & Crane S (1992) Effect of oatbran on mild hyperlipidaemia. Med J Aust 157, 305-308.
38. Liatis S, Tsapogas P, Chala E, et al. (2009) The consumption of bread enriched with betaglucan reduces LDL-cholesterol and improves insulin resistance in patients with type 2 diabetes. Diabetes Metab 35, 115-120.
39. Lovegrove JA, Clohessy A, Milon H, et al. (2000) Modest doses of beta-glucan do not reduce concentrations of potentially atherogenic lipoproteins. Am J Clin Nutr 72, 49-55.
40. Maki CK, Davidson HM, Ingram AK, et al. (2003) Lipid responses to consumption of a beta-glucan containing readyto-eat cereal in children and adolescents with mildto-moderate primary hypercholesterolemia. Nutr Res 23, 1527-1535.
41. Maki KC, Beiseigel JM, Jonnalagadda SS, et al. (2010) Wholegrain ready-to-eat oat cereal, as part of a dietary program for weight loss, reduces low-density lipoprotein cholesterol in adults with overweight and obesity more than a dietary program including low-fiber control foods. J Am Diet Assoc 110, 205-214.
42. Mårtensson O, Biörklund M, Lambo AM, et al. (2005) Fermented, ropy, oat-based products reduce cholesterol levels and stimulate the bifidobacteria flora in humans. Nutr Res 25, 429-442.
43. Momenizadeh A, Heidari R, Sadeghi M, et al. (2014) Effects of oat and wheat bread consumption on lipid profile, blood sugar, and endothelial function in hypercholesterolemic patients: a randomized controlled clinical trial. ARYA Atheroscler 10, 259-265.
44. Noakes M, Clifton PM, Nestel PJ, et al. (1996) Effect of highamylose starch and oat bran on metabolic variables and bowel function in subjects with hypertriglyceridemia. Am J Clin Nutr 64, 944-951.
45. Onning G, Wallmark A, Persson M, et al. (1999) Consumption of oat milk for 5 weeks lowers serum cholesterol and LDL cholesterol in free-living men with moderate hypercholesterolemia. Ann Nutr Metab 43, 301-309.
46. Queenan KM, Stewart ML, Smith KN, et al. (2007) Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr J 6, 6.
47. Reyna-Villasmil N, Bermudez-Pirela V, Mengual-Moreno E, et al. (2007) Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia. Am J Ther 14, 203-212.
48. Reynolds HR, Quiter E & Hunninghake DB (2000) Whole grain oat cereal lowers serum lipids. Top Clin Nutr 15, 74-83.
49. Romero AL, Romero JE, Galaviz S, et al. (1998) Cookies enriched with psyllium or oat bran lower plasma LDL cholesterol in normal and hypercholesterolemic men from Northern Mexico. J Am Coll Nutr 17, 601-608.
50. Stewart FM, Neutze JM & Newsome-White R (1992) The addition of oatbran to a low fat diet has no effect on lipid values in hypercholesterolaemic subjects. N Z Med J 105, 398-400.
51. Theuwissen E & Mensink RP (2007) Simultaneous intake of beta-glucan and plant stanol esters affects lipid metabolism in slightly hypercholesterolemic subjects. J Nutr 137, 583-588.
52. Thongoun P, Pavadhgul P, Bumrungpert A, et al. (2013) Effect of oat consumption on lipid profiles in hypercholesterolemic adults. J Med Assoc Thai 96, Suppl. 5, S25-S32.
53. Turnbull WH & Leeds AR (1987) Reduction of total and LDL-cholesterol in plasma by rolled oats. J Clin Nutr Gastroentrol 2, 177-181.
54. Uusitupa MI, Ruuskanen E, Makinen E, et al. (1992) A controlled study on the effect of beta-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: relation to apolipoprotein E phenotype. J Am Coll Nutr 11, 651-659.
55. Van Horn L, Moag-Stahlberg A, Liu KA, et al. (1991) Effects on serum lipids of adding instant oats to usual American diets. Am J Public Health 81, 183-188.
56. Van Horn L, Liu K, Gerber J, et al. (2001) Oats and soy in lipidlowering diets for women with hypercholesterolemia: is there synergy? J Am Diet Assoc 101, 1319-1325.
57. Whyte JL, McArthur R, Topping D, et al. (1992) Oat bran lowers plasma cholesterol levels in mildly hypercholesterolemic men. J Am Diet Assoc 92, 446-449.
58. Wolever TM, Tosh SM, Gibbs AL, et al. (2010) Physicochemical properties of oat β-glucan influence its ability to reduce serum LDL cholesterol in humans: a randomized clinical trial. Am J Clin Nutr 92, 723-732.
59. Zhang J, Li L, Song P, et al. (2012) Randomized controlled trial of oatmeal consumption versus noodle consumption on blood lipids of urban Chinese adults with hypercholesterolemia. Nutr J 11, 54.
60. Beck EJ, Tapsell LC, Batterham MJ, et al. (2010) Oat betaglucan supplementation does not enhance the effectiveness of an energy-restricted diet in overweight women. Br J Nutr 103, 1212-1222.
61. Chen J, He J, Wildman RP, et al. (2006) A randomized controlled trial of dietary fiber intake on serum lipids. Eur J Clin Nutr 60, 62-68.
62. Cugnet-Anceau C, Nazare JA, Biorklund M, et al. (2010) A controlled study of consumption of beta-glucan-enriched soups for 2 months by type 2 diabetic free-living subjects. Br J Nutr 103, 422-428.
63. Davy BM, Davy KP, Ho RC, et al. (2002) High-fiber oat cereal compared with wheat cereal consumption favorably alters LDL-cholesterol subclass and particle numbers in middle-aged and older men. Am J Clin Nutr 76, 351-358.
64. Gerhardt AL & Gallo NB (1998) Full-fat rice bran and oat bran similarly reduce hypercholesterolemia in humans. J Nutr 128, 865-869.
65. Gold KV & Davidson DM (1988) Oat bran as a cholesterolreducing dietary adjunct in a young, healthy population. West J Med 148, 299-302.
66. Ibrugger S, Kristensen M, Poulsen MW, et al. (2013) Extracted oat and barley beta-glucans do not affect cholesterol metabolism in young healthy adults. J Nutr 143, 1579-1585.
67. Kabir M, Oppert JM, Vidal H, et al. (2002) Four-week lowglycemic index breakfast with a modest amount of soluble fibers in type 2 diabetic men. Metabolism 51, 819-826.
68. Ma X, Gu J, Zhang Z, et al. (2013) Effects of Avena nuda L. on metabolic control and cardiovascular disease risk among Chinese patients with diabetes and meeting metabolic syndrome criteria: secondary analysis of a randomized clinical trial. Eur J Clin Nutr 67, 1291-1297.
69. McGeoch SC, Johnstone AM, Lobley GE, et al. (2013) A randomized crossover study to assess the effect of an oat-rich diet on glycaemic control, plasma lipids and postprandial glycaemia, inflammation and oxidative stress in type 2 diabetes. Diabet Med 30, 1314-1323.
70. Naumann E, van Rees AB, Onning G, et al. (2006) Beta-glucan incorporated into a fruit drink effectively lowers serum LDL-cholesterol concentrations. Am J Clin Nutr 83, 601-605.
71. Pick ME, Hawrysh ZJ, Gee MI, et al. (1996) Oat bran concentrate bread products improve long-term control of diabetes: a pilot study. J Am Diet Assoc 96, 1254-1261.
72. Pins JJ, Geleva D, Keenan JM, et al. (2002) Do whole-grain oat cereals reduce the need for antihypertensive medications and improve blood pressure control? J Fam Pract 51, 353-359.
73. Poulter N, Chang CL, Cuff A, et al. (1994) Lipid profiles after the daily consumption of an oat-based cereal: a controlled crossover trial. Am J Clin Nutr 59, 66-69.
74. Robitaille J, Fontaine-Bisson B, Couture P, et al. (2005) Effect of an oat bran-rich supplement on the metabolic profile of overweight premenopausal women. Ann Nutr Metab 49, 141-148.
75. Saltzman E, Das SK, Lichtenstein AH, et al. (2001) An oatcontaining hypocaloric diet reduces systolic blood pressure and improves lipid profile beyond effects of weight loss in men and women. J Nutr 131, 1465-1470.
76. Swain JF, Rouse IL, Curley CB, et al. (1990) Comparison of the effects of oat bran and low-fiber wheat on serum lipoprotein levels and blood pressure. N Eng J Med 322, 147-152.
77. Van Horn L, Emidy LA, LiuKA, et al. (1988) Serum lipid response to a fat-modified, oatmeal-enhanced diet. Prev Med 17, 377-386.
78. Zhang JX, Hallmans G, Andersson H, et al. (1992) Effect of oat bran on plasma cholesterol and bile acid excretion in nine subjects with ileostomies. Am J Clin Nutr 56, 99-105.
79. Brown L, Rosner B, Willett WW, et al. (1999) Cholesterollowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 69, 30-42.
80. Bartlomiej S, Justyna RK & Ewa N (2012) Bioactive compounds in cereal grains-occurrence, structure, technological significance and nutritional benefits-a review. Food Sci Technol Int 18, 559-568.
81. Lee CJ, Horsley RD, Manthey FA, et al. (1997) Comparisons of β-glucan content of barley and oat. Cereal Chem J 74, 571-575.